Association of apolipoprotein E genotype and cerebral palsy in children

Maxine M Kuroda1, Mary E Weck, John F Sarwark

  • 1Department of Pediatrics, Division of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Pediatrics
|February 3, 2007
PubMed

Insights

Apolipoprotein E (APOE) epsilon4 and epsilon2 genotypes are linked to increased cerebral palsy risk. Children with severe neurological impairment were more likely to carry the APOE epsilon4 allele.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Cerebral palsy (CP) is a group of disorders affecting movement and posture.
  • The role of genetic factors, such as apolipoprotein E (APOE) genotype, in CP development is under investigation.
  • APOE epsilon4 allele carriage has been hypothesized to be associated with CP.

Purpose of the Study:

  • To investigate the association between apolipoprotein E genotype and cerebral palsy.
  • To determine if children with more severe neurological impairment are more likely to carry the APOE epsilon4 allele.

Main Methods:

  • A cross-sectional study involving 209 children with cerebral palsy matched with healthy controls.
  • APOE genotyping performed using DNA from buccal swabs.
  • Severity of motor impairment assessed by physical therapists; occipitofrontal circumference measured.

Main Results:

  • Overall risk for cerebral palsy was 3.4-fold higher in children carrying the APOE epsilon4 allele, particularly those with quadriplegia/triplegia.
  • APOE epsilon4 carriage was associated with increased cerebral palsy severity and a trend toward microcephaly.
  • APOE epsilon2 allele carriage was also linked to a greater risk of cerebral palsy.

Conclusions:

  • APOE epsilon4 and epsilon2 genotypes are implicated as susceptibility factors for cerebral palsy and adverse neurologic outcomes post-perinatal brain injury.
  • Further research is needed to elucidate the specific pathogenetic roles of APOE in cerebral palsy development.
Abstract